New Physician Advisory Committee Launched by the
National Association for Proton Therapy
Committee Includes National Leaders in Radiation Oncology and Proton Therapy
Washington, D.C., December 21, 2020: To guide the National Association for Proton Therapy, the organization has created a NEW Physician Advisory Committee. The Committee will advise NAPT on critical issues including advancing clinical research collaboration, patient education and equitable insurance reimbursement practices.
Chaired by J. Isabelle Choi, MD, Clinical Director and Research Director of the New York Proton Center and Assistant Member at Memorial Sloan Kettering Cancer Center, the Committee is comprised of experts representing the leading radiation oncology and proton therapy centers such as Mayo Clinic, Emory Proton Center, Miami Cancer Institute, and MD Anderson Cancer Center.
“We are excited that Dr. Choi will be chairing the Physician Advisory Committee,” said Jennifer Maggiore, Executive Director, NAPT. “Dr. Choi’s efforts to advance proton therapy research and improve outcomes for cancer patients makes her a terrific leader in this new role.”
Under Dr. Choi’s leadership, the NAPT Physician Advisory Committee will be positioned to support the mission and goals of the association by promoting the benefits of proton therapy, collaborating with other cancer-related stakeholders, and supporting proton therapy research.
“I’m pleased to lead these expert proton therapy physicians who can help the organization expand insurance coverage guidelines, develop clinical trials, and promote the collaboration of proton therapy disease-specific research summaries for patients and those supporting access to proton therapy,” said Dr. Choi.
Before coming to the New York Proton Center, Dr. Choi was an Assistant Professor at the University of Maryland School of Medicine and served as a clinical lead of the Maryland Proton Treatment Center. She was previously the Clinical Director at the California Protons Cancer Therapy Center in San Diego, where she also served as the Associate Director of Clinical Research and the Chief of the Breast Cancer, Thoracic Oncology, and Gynecologic Services.
In addition to her chairing NAPT’s Physician Advisory Committee, Dr. Choi is Chair of the Proton Collaborative Group Publications Committee and Breast Subcommittee and is the President of the Korean American Society of Radiation Oncology.
For more information about NAPT, visit www.proton-therapy.org.
Founded in 1990, NAPT is a nonprofit organization that educates and increases awareness about the benefits of proton therapy. As one of the most advanced methods of radiation treatment, proton therapy allows radiation treatment doses to be delivered to cancerous tumors while minimizing radiation exposure to healthy tissues and organs that results in the potential for fewer short and long term side effects. NAPT works to educate and raise awareness of proton therapy, ensure patient choice and access to proton therapy, and encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy. NAPT’s supporting members include 36 of the nation’s leading cancer centers, some of whom are National Cancer Institute-designated comprehensive cancer centers and National Comprehensive Care Network (NCCN) members.